Interventional Radiology : Useful for All and Always ?

Slides:



Advertisements
Similar presentations
BENIGN VS MALIGNANT MASSES IN BREAST ULTRASOUND
Advertisements

Golan.O, Sperber.F, Shalmon.A, Weinstein.I, Gat.A
Breast Imaging Olga Hatsiopoulou Consultant Radiologist
Histopathology and Cytology for Breast lesions Britt-Marie Ljung MD Professor of Pathology, Dir. of Cytology University of California at San Francisco.
MICROCALCIFICATION IN BENIGN BREAST DISEASE
BREAST CANCER UPDATE DETECTION TO DIAGNOSIS
MCQs On Breast Imaging:
Pathology Journal Reading
In The Nam of God.
Breast Pathology Dr. M. Griffin.
What to Expect When a Lump Is Detected
Breast Imaging Made Brief and Simple
Minimally Invasive Breast Procedures F. Sperber, M.D. Breast Imaging Center Sourasky Medical Center Tel Aviv University.
Faculty of Medicine - Benha University
Improved Design for Fine-Needle Aspiration (FNA) of Breast Cancer Lesions Alissa Garman Janie Goldsworthy Kristi Hinner Nick Kortan Client: Elizabeth Burnside.
Tissue Sampling Options Lisa A. Newman, M.D., M.P.H., F.A.C.S. Professor of Surgery Director, Breast Care Center University of Michigan Ann Arbor, MI.
FINE - NEEDLE ASPIRATION BIOPSY By Dr. Tarek Atia.
In The Nam of God.
Ductal Carcinoma In-Situ (DCIS)
Proliferative Epithelial lesions of the Breast
Breast Pathology Seminar CASE PRESENTATION PART 1 Elba Torres Matundan MD FCAP Victor Carlo Vargas MD FCAP.
ASSESSMENT OF BREAST SYMPTOMS/LUMPS Professor P Grantley Gill Specialists Without Borders Seminar in Surgery Rwanda, September 2010.
Elshami M.Elamin, MD Medical Oncologist Central Care Cancer Center Wichita, KS, USA
Alireza Mohammadzadeh, MD Thoracic Surgeon
BI-RADS By Nina Zahedi MD.
Bayesian Network for Predicting Invasive and In-situ Breast Cancer using Mammographic Findings Jagpreet Chhatwal1 O. Alagoz1, E.S. Burnside1, H. Nassif1,
Approach to a thyroid nodule
Marion C.W. Henry, MD Yale University
SYB 1 Erin Gundersen MS IV. Breast Cancer Breast Cancer.
FNA of breast Slide session The 6th Arab-British School of Pathology
WORK UPS. Ultrasound method of choice for the differentiation of cysts from solid masses and for guidance in interventional procedures. Benign: – solid.
Session 5. Case Diagnosis - Sclerosing adenosis with lobular neoplasia. No invasion in images provided.
Ch 35 BREAST CANCER 부산백병원 산부인과 R1 서 영 진 R1 서 영 진.
Thyroid Nodules Hollis Moye Ray, MD SEAHEC Internal Medicine June 3, 2011.
The Breast Clinic Index case Year 2 Michaelmas term.
Imaging examinations of breasts
Breast Conference 7/13/2011. RC AAF presenting with abnormal mammogram.
Introduction to Breast Imaging BREAST RAD LAB Directions: Please answer all the questions prior to interactive conference. 1.
Breast Calcifications - Differential diagnosis and BIRADS
Breast cancer -most common -Second common ( Death ) new case ( 2003 ) diagnosed - Lifetime Risk 2.5 % ( 1-8 )
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Introduction to Clinical Radiology: The Breast
Breast Diagnosis And Management of of Benign Breast Diseases Resident Basic Science Harry D. Bear, MD, PhD Division of Surgical Oncology Massey.
PERCUTANEOUS CT-GUIDED BIOPSY OF THE MUSCULO-SKELETAL SYSTEM: RESULTS OF 1722 CASES E. Rimondi, P. Ruggieri, G. Bosco, G. Ussia, T. Calabrò, A. Angelini,
Evaluation of Thyroid Nodules
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
BREAST CANCER: Half a million women later… Amy Miglani M.D September 3, 2004.
Lesioni a cellule colonnari CON atipie (FEA/DIN1A) Lesioni a rischio evolutivo? Escissione sempre? SI ?
Jeddah Breast Cancer Pilot Screening Program, KSA Muna Baslaim, MD Consultant Surgeon Head of the Breast Unit, King Fahd General Hospital Jeddah, Saudi.
Breast Tumors Diagnosed as Papillary Neoplasm by FNAB Dae-Kyum Kim, Sang-Uk Woo, Jeong-Han Kim, Seok-Jin Nam, Yoon-La Choi 1, Young-Lyun Oh 1 and Jung-Hyun.
British/ Arab School of Pathology, June 2008 Slide Seminars.
Screening mammography
OVERVIEW OF BREAST PATHOLOGY Shahin Sayed, MMed, FCPath(ECSA) Assistant Professor, Department of Pathology, Aga Khan University Hospital, Nairobi.
Investigations of Breast Cancer -by preetam goswami 8th semester,unit-1.
Application of the breast imaging reporting and data system final assessment system in sonography of palpable breast lesions and reconsideration of the.
BI-RADS classification in mammography
Ultrasound breast core needle biopsy
6ème PAIRS-Hammamet-Tunis-avril2012
Dr. Amit Gupta Associate Professor Dept Of Surgery
Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation Reshma Ariga, M.D., Kenneth Bloom, M.D., Vijaya.
Sonography of the Breast Part III Lecture 12 Invasive Procedures
 [P1]Can you put in the numbers here for specificity and NPV
Is ultrasound valuable in breast cancer screening
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
Current Status of Breast Ultrasound
Pathologic Upgrade Rates of High-Risk Breast Lesions on Digital Two-Dimensional vs Tomosynthesis Mammography  Leslie R. Lamb, MD, MSc, Manisha Bahl, MD,
Avoiding Pitfalls in Mammographic Interpretation
Solitary Thyroid Nodule Aisha Abu Rashed
Pediatric Cervical Hodgkin’s Lymphoma Diagnosed by Ultrasound-guided Core Needle Biopsy A case report Chi-Maw Lin, MD Department of Otolaryngology, Head.
Marion C.W. Henry, MD Yale University
Presentation transcript:

Interventional Radiology : Useful for All and Always ? Dr S. Murgo CHU Tivoli, La Louvière, Belgique Hôpital Erasme, Bruxelles, Belgique

Introduction Screening  Many benign lesions indistinguishable from cancer  Previously open surgical biopsies (OSB) for asymptomatic benign lesions were often necessary  Quick development of percutaneaous biopsies for BIRADS 4 and also 5  with often a lack of scientific validations  some controversies

Potential advantages Less invasive, less expansive techniques that avoid: surgery for benign lesions surgery in 2 times Percutaneaous biopsy may avoid per-operative histological analysis that may destruct small lesions

Potential drawbacks Epithelial displacement (FNA, CNB > VACB): No evidence of biologic significance No  of the recurrence rate after BCS But some displaced cells associated with DCIS can sometime mimic IDC for pathologist. Risk of missed cancers  good knowledge of limitations

Interventional Radiology Includes: Guidewire Localization RadioFrequency Fine Needle Aspiration Core Needle Biopsy Large Core Needle Biopsy

Architectural Distorsion Main Mammographic Signs Mass Architectural Distorsion Microcalcifications

Mass: with irregular / stellate outline DD: Radial scar, complex sclerosis lesion, invasive carcinoma (usually grade I or II), fat necrosis, granular cell myoblastoma,… FNA ?  10 % of C1 (not enough cells)  CNB  False negative: 6-7% (1)  C2 no value  PPV of C3 : 55 % if suspect 83% (2)  PPV of C4 : 96 % if suspect 98.5 % (2)  PPV of C5 > 99.4 % (2)  invasive carcinoma ?  CNB Lau. The breast Journal 2004; 10: 487 Bulgaresi. Breast cancer Res Treat 2006; 97 (3):319-21

Mass: CNB 14 g – with 3 samples in the target Koskela. Radiology 2005; 236: 801-9

Mass: with well-defined outline DD: Cyst, FA, hamartoma, lymph node, phyllodes tumor, invasive carcinoma (high grade), papillary lesions, mucinous carcinoma, medullary carcinoma, abscess Ultrasound 1 - Typical cyst, harmatoma, or LN  STOP 2 – « Typical FA »  different schools: Follow-up ? Not palpable  0-2 % of malignancy (mean: 1.4% - Lower for young women (< 30 yo)) Triple test with FNA ? Negative predictive value:  100% (1) but … false positive ! CNB the best test to exclude a breast cancer ! Especially for large lesion and old women (> 60 % of carcinoma after 60 yo) Lau. The breast Journal 2004. 10: 487

(3 samples in the target) ? FA ? Not palpable 98.6 % of benign lesions (1) 6 mo follow-up FNA CNB No change after 2 y Change C1 10-15 %  CNB (3) Best test 99.9 % B  0.1% M (7% of 1.4% BC) C2 NPV  100 % PPV > 98 % (3 samples in the target) CNB 0.026% of missed cancers (after 3 years) (2)  C3 7-8 %  CNB (4) 16 % of cancers 86.1 % of T0N0M0 or T1N0M0 (2) Sickles. Radiol Clin North. Am 1995; 33:1123-1130. Sickles. Radiology 1999; 213:11-14. Wells. EU guidelines for non-operative diagnostic procedures. 2004 Lau. The breast Journal 2004; 10: 487

Tabar. Radiol Ciln North Am. 2000; 38(4):625-651

(3 samples in the target) FA ? Not palpable 98.6 % of benign lesions (1) 6 mo follow-up FNA CNB No change after 2 y Change C1 10 %  CNB (3) Best test 99.9 % B  0.1% M (7% of 1.4% BC) C2 NPV  100 % PPV > 98 % (3 samples in the target) CNB Missed cancers 0.026% (after 3 years) (2)  C3 7-8 %  CNB (4) 16 % of cancers 86.1 % of T0N0M0 or T1N0M0 (2) Sickles. Radiol Clin North. Am 1995; 33:1123-1130. Sickles. Radiology 1999; 213:11-14. Wells. EU guidelines for non-operative diagnostic procedures. 2004 Lau. The breast Journal 2004; 10: 487 Caution: size , age, other risk factors (BRCA, family or personal history,...), anxiety and reliability of the pat.

Well-defined mass Ultrasound Open Surgical Biopsy ! 3 – Cystic lesion with intracystic growth 40 women with 56 papillary lesions: 3 papillary carcinomas, 13 papillaryal lesions with carcinoma in situ, 1 atypical carcinoma, 4 sclerosed papilloma, 35 papillomata. PPV NPV FNA 31 % 79 % CNB 100 % 83 % Lam. AJR 2006; 186(5): 1322-7 Open Surgical Biopsy !

Well-defined mass 50 papillomas on percutaneous biopsy (35 VACB – 11G & 15 CNB 14 G) Reference standard: OSB and longterm follow-up  5 (14%) breast cancers (4 DCIS & 1 inv. carcinoma)  6 (17%) high risk lesions (3 ADH, 2 radial scar, 1 LN) The risk  in case of multiple papilloma and with a family history of breast cancer Liberman. AJR 2006; 186(5): 1328-34 Open Surgical Biopsy ! Can we totally remove a small benign lesion with LCNB ? …

Architectural distortion DD: Involution, radial scar, invasive lobular carcinoma, DCIS(rarely),… Radial scar: Fibroelastic center with pseudo-infiltrative tubular structure (DD: tub car). In the crown of the RS +/- ADH, ALH, DCIS, LN, … the risk  with the age and the size (1) - None < 40 yo, rare between 40 & 50 yo,  > 50 yo - Rare if < 6-7 mm Open Surgical Biopsy ! Andersen JA, Cancer 1984; 53:2557-2560.

Architectural distortion Open Surgical Biopsy ! From Tabar. Practical breast pathology - Thieme 2002: 104-5

Mammographic appearence of breast cancers Microcalcifications Mammographic appearence of breast cancers

Mammographic appearence of calcifications sent to surgery Microcalcifications Mammographic appearence of calcifications sent to surgery

Microcalcifications Casting calcifications (fine, linear, branching): plasma cell mastitis, DCIS grade III. Crushed stone calcifications (pleomorphic, heterogenous): Fat necrosis, FA, cysts, DCIS grade II/III, Lobular neoplasia (rarely). Powdery calcifications (amorphous, indistinct): sclerosing adenosis, cysts, DCIS grade I/II. Wells. EU guidelines for non-operative diagnostic procedures. 2004

Microcalcifications: CNB Koskela. Radiology 2005; 236: 801-9

Vacuum assisted breast biopsy Mammotome® Vacora®

Large biopsy En-bloc ® … SiteSelect ® (ABBI ®)

On stereotactic guidance Lateral position - LM

Dedicated table Lorad Fisher

Microcalcifications VACB > CNB with a higher NPV and less technical failures Meta-analysis: 35 studies – minimal invasive breast biopsy after screening: 12 VABB, n = 5119 25 CNB, n = 6236 Reference standard: open surgery or longterm follow-up VACB CNB Overall agreement with reference 97.3 % 93.5 % Technical failure 1.5 % 5.7 % Non diagnostic samples 0 % 2.1 % (23 % of BC)  FN : 3.8 % Fahrbach. Arch gynecol obstet 2006; 274(2):63-74

To reach a high NPV: MG of samples Post biopsy MG

With CNB, the sensitivity  with the number of samples Koskela. Radiology 2005; 236: 801-9

Microcalcifications With VACB - 11 G under stereotactic guidance Mass Microcalcification With VACB - 11 G under stereotactic guidance The accuracy increase significantly until 12 samples Lomoschitz. Radiology 2004; 232:897–903

Calcifications : undervaluation Vacuum-assisted devices, larger gauge biopsy needles, and greater number of cores were associated with a higher NPV. But there is always some underevaluated lesions: ADH, ALH, LN, DCIS (16-31 %)  OSB is required Magenthaler. Am J Surg 2006; 192(4):534-7 Mahoney. AJR 2006; 187(4):949-54 Lomoschitz. Radiology 2004; 232:897–903

Calcifications : undervaluation Large cluster of amorphous calcifications: adenosis +/- DCIS ? Tabar. Practical breast pathology - Thieme 2002

Microcalcifications To avoid missed cancer, a open surgical biopsy is required after percutaneous biopsy: When none or a small number of calcifications are removed For large cluster of amorphous calcifications (adenosis +/- DCIS ?) For an histological diagnosis of ADH, ALH, and LN

Conclusions IR is very useful and efficient BUT not for all and always ! The knowledge of the limitations of each techniques   nb of missed cancers Confrontation of the cytological and histological results with the PE and medical imaging studies in a multidisciplinary approach ! Repeat biopsy is necessary if histological and imaging finding are discordant Surgical excision is necessary for some histological benign lesions: ADH, ALH, LN, radial scar, papillary lesions, possible phyllode tumor

Conclusions Further work is necessary to optimize criteria for patient selection, to develop and define the role of new technologies. Complete removal of the mammographic target does not ensure complete excision of the histological process  Further investigation is necessary to determinate in which lesion, complete removal of the target is advantageous.